3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Colorectal Neoplasms
6
Stomach Neoplasms
3
Polyps
2
Neoplasms
2
Laryngeal Diseases
2
Hypopharyngeal Neoplasms
2
Carcinoma, Squamous Cell
2
Barrett Esophagus
2
Adenomatous Polyps
2
Adenoma
2
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Papilloma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Nasopharyngeal Carcinoma
1
Margins of Excision
1
Lung Neoplasms
1
Laryngeal Neoplasms
1
Inflammatory Bowel Diseases
1
Hypersensitivity
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colonic Polyps
1
Interventions
pembrolizumab
180
Gemcitabine
168
Paclitaxel
150
Carboplatin
134
Bevacizumab
126
Cisplatin
113
Docetaxel
112
Cyclophosphamide
109
Exercise
97
Nivolumab
92
Fluorouracil
88
Capecitabine
85
Dexamethasone
81
Irinotecan
74
Radiotherapy
68
Oxaliplatin
68
Pemetrexed
66
Standard of Care
64
Leucovorin
63
Cetuximab
59
Sorafenib
53
Erlotinib Hydrochloride
53
Drug Therapy
53
Blood Specimen Collection
52
Doxorubicin
50
trametinib
47
atezolizumab
47
Ipilimumab
47
Albumin-Bound Paclitaxel
44
130-nm albumin-bound paclitaxel
42
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Neoplasms
×
Narrow Band Imaging
×
Clear all
NCT02929381
2016-10-11
AEI
Jagiellonian University
Phase NA
Unknown
400 enrolled
NCT01688557
2016-10-07
RCT-IC
Jagiellonian University
Phase NA
Completed
600 enrolled